D037161Chemicals & DrugsD12.776.503.307890.987176Galectinsprns:emailEncryptedemail addressprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation Resourcevivo:linkAnchorTextlink anchor textPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forURLLinkvivo:webpagewebpagerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonPediatrics-Allergy & Immunology31902327Sharma A, Vaduganathan M, Ferreira JP, Liu Y, Bakris GL, Cannon CP, White WB, Zannad FJournal of the American Heart AssociationClinical and Biomarker Predictors of Expanded Heart Failure Outcomes in Patients With Type 2 Diabetes Mellitus After a Recent Acute Coronary Syndrome: Insights From the EXAMINE Trial. J Am Heart Assoc. 2020 01 07; 9(1):e012797.J Am Heart Assoc2020-01-04T00:00:002020Clinical and Biomarker Predictors of Expanded Heart Failure Outcomes in Patients With Type 2 Diabetes Mellitus After a Recent Acute Coronary Syndrome: Insights From the EXAMINE Trial.Medicine-Hematology and Oncology31291985Dama P, Tang M, Fulton N, Kline J, Liu HJournal for immunotherapy of cancerGal9/Tim-3 expression level is higher in AML patients who fail chemotherapy. J Immunother Cancer. 2019 07 10; 7(1):175.J Immunother Cancer2019-07-10T00:00:002019Gal9/Tim-3 expression level is higher in AML patients who fail chemotherapy.33941700Farhadi SA, Liu R, Becker MW, Phelps EA, Hudalla GAProceedings of the National Academy of Sciences of the United States of AmericaPhysical tuning of galectin-3 signaling. Proc Natl Acad Sci U S A. 2021 05 11; 118(19).Proc Natl Acad Sci U S A2021-05-11T00:00:002021Physical tuning of galectin-3 signaling.SharmileeNyenhuisSharmilee Nyenhuis41.7886000000000087.598699999999994148Nyenhuis, SharmileeAssociate Professor31157540Nyenhuis SM, Alumkal P, Du J, Maybruck BT, Vinicky M, Ackerman SJBiomarkers in medicineCharcot-Leyden crystal protein/galectin-10 is a surrogate biomarker of eosinophilic airway inflammation in asthma. Biomark Med. 2019 06; 13(9):715-724.Biomark Med2019-06-03T00:00:002019Charcot-Leyden crystal protein/galectin-10 is a surrogate biomarker of eosinophilic airway inflammation in asthma.1.379170.04454148research area of0.8190240.1371949subject area forhttps://klinelab.uchicago.edu/My Lab SitePathologyUniversity of ChicagoGeorgeBakris0GBoa7McCszMknJtY0fp/Cv/+94=George Bakris41.78927490000000-87.601250000000001393Bakris, GeorgeProfessorJustin P.Kline3WllAq8QOfnamXNnYUHhvWD+6g==Justin P. Kline41.78927490000000-87.601250000000001922Kline, Justin P.ProfessorGregoryHudallaGregory Hudalla41.78927490000000-87.601250000000002592Hudalla, GregoryThomas N.KrauszThomas N. Krausz41.78927490000000-87.60125000000000525Krausz, Thomas N.Clinical Professortrue1true1ProfessorProfessortrue1ProfessorProfessortrue1Clinical ProfessorClinical Professortrue1Associate ProfessorAssociate ProfessorMedicine-Endocrinology27229902Farhadi SA, Hudalla GAExperimental biology and medicine (Maywood, N.J.)Engineering galectin-glycan interactions for immunotherapy and immunomodulation. Exp Biol Med (Maywood). 2016 05; 241(10):1074-83.Exp Biol Med (Maywood)2016-05-01T00:00:002016Engineering galectin-glycan interactions for immunotherapy and immunomodulation.